Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon Aug 24, 2023 10:46am
108 Views
Post# 35603689

Me? Smart?

Me? Smart?
I don't know. I don't claim I'm smart, but it's clear that my intelligence and knowledge are very intimidating to you, TheTruth1234.
 
You're the one talking only about me, with a little Sappy Cap lately thrown in.
 
I'm the one talking about Bioasis, Ladenberg Thalmann, Midatech, Biodexa, Cresence, DrDR and Brother Mario, and why they spent almost two years trying to get this deal done.
 
Why did they do it, TT?
 
What was their play? What did they all want?
 
Come on. Give it up.
 
They wanted the only thing that was worth anything in the deal, xB3.
 
This is getting embarrassing, TT. One should never attribute to malice that which one can attribute to ignorance.
 
This is an exception. I'm seeing a lot of malice from you, TT, and hate. And too much ignorance,  as well, sadly.
 
It's of Craig Henry proportions.
 
A complete loss of sanity and judgment.

And too much repetition.

Einstein said that repeating the same thing over and over and expecting different results is the definition of insanity.

Simply put, you cannot embarrass me, TT. Not possible. No matter how repetitive you are.

You're in over your head.

xB3 may ultimately fail, but LT and the Gang, including Rathjen and Saltarelli, want to acquire it.

They have the inside information, TT, not you. They have more knowledge than I do. They want xB3 and Rathjen has been willing to embarrass herself to get it.

Pretty good bet that they all have a lot of confidence in xB3, and that those faded deals will rise again if those players have payloads worth transporting across the BBB with xB3.

We'll know soon enough. If Rathjen announces another deal, then it means they and she want xB3. It can mean nothing else. Other than that, the Bioasis shareholders lost, big time, not because of xB3, but because of Rathjen.

jd

 
<< Previous
Bullboard Posts
Next >>